The pharmaceutical marketplace tells thousands of stories, but it takes an expert to translate them. IMS speaks 'marketplace' fluently.
IMS helps customers identify an optimal mix of products in their portfolios and pipelines to advance healthcare and produce the best returns. For example, we work with our customers to determine which therapy classes to enter ... which products to develop and license ... how to achieve the right marketing mix ... and what acquisitions to consider.
Our Portfolio Optimization solutions in the Asia-Pacific region help clients assess current and future product potential, enabling them to allocate resources across their portfolios to maximize performance.
In a market driven by innovation, IMS measures the performance of global product portfolios, delivers high-impact solutions and helps answer mission-critical questions.
